News Update: Ariad Pharma Reports Inline Loss, Will Offer Guidance After Merck Agreement Finalized
Rate:
1,017 ratings
Views: 82
From: TradeTheTrend
Added: 16 years ago · 1:15 · 480p
3/16/2010-Ariad Pharmaceuticals (NASDAQ:ARIA) reported a Q4 loss of $0.17 per share, in line with consensus estimates.
Comments
No comments yet.